These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22071777)

  • 1. Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response.
    Eisa F; Brauweiler R; Hupfer M; Nowak T; Lotz L; Hoffmann I; Wachter D; Dittrich R; Beckmann MW; Jost G; Pietsch H; Kalender WA
    Eur Radiol; 2012 Apr; 22(4):900-7. PubMed ID: 22071777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
    Wang H; Hristov D; Qin J; Tian L; Willmann JK
    Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
    Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.
    Messiou C; Orton M; Ang JE; Collins DJ; Morgan VA; Mears D; Castellano I; Papadatos-Pastos D; Brunetto A; Tunariu N; Mann H; Tessier J; Young H; Ghiorghiu D; Marley S; Kaye SB; deBono JS; Leach MO; deSouza NM
    Radiology; 2012 Nov; 265(2):426-36. PubMed ID: 22891356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
    Ren Y; Fleischmann D; Foygel K; Molvin L; Lutz AM; Koong AC; Jeffrey RB; Tian L; Willmann JK
    Invest Radiol; 2012 Jan; 47(1):25-32. PubMed ID: 22178893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
    Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
    Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
    Jost G; Pietsch H; Grenacher L
    Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-early changes in vascular parameters from dynamic contrast enhanced MRI of breast cancer xenografts following systemic therapy with doxorubicin and liver X receptor agonist.
    Pitman KE; Bakke KM; Kristian A; Malinen E
    Cancer Imaging; 2019 Dec; 19(1):88. PubMed ID: 31856923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT.
    Fournier LS; Oudard S; Thiam R; Trinquart L; Banu E; Medioni J; Balvay D; Chatellier G; Frija G; Cuenod CA
    Radiology; 2010 Aug; 256(2):511-8. PubMed ID: 20551183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.
    Hwang SH; Yoo MR; Park CH; Jeon TJ; Kim SJ; Kim TH
    Eur Radiol; 2013 Jun; 23(6):1573-81. PubMed ID: 23300040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.
    Raatschen HJ; Fu Y; Brasch RC; Pietsch H; Shames DM; Yeh BM
    Invest Radiol; 2009 May; 44(5):265-70. PubMed ID: 19346961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy.
    Sabir A; Schor-Bardach R; Wilcox CJ; Rahmanuddin S; Atkins MB; Kruskal JB; Signoretti S; Raptopoulos VD; Goldberg SN
    AJR Am J Roentgenol; 2008 Jul; 191(1):133-9. PubMed ID: 18562736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI.
    Kim E; Kim J; Maelandsmo GM; Johansen B; Moestue SA
    Magn Reson Med; 2017 Oct; 78(4):1513-1522. PubMed ID: 27888545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.
    Zhou J; Zhang H; Wang H; Lutz AM; El Kaffas A; Tian L; Hristov D; Willmann JK
    Angiogenesis; 2017 Nov; 20(4):547-555. PubMed ID: 28721500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
    Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
    AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.
    Zhu W; Kato Y; Artemov D
    MAGMA; 2014 Apr; 27(2):161-70. PubMed ID: 23807596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats.
    Pollard RE; Broumas AR; Wisner ER; Vekich SV; Ferrara KW
    Ultrasound Med Biol; 2007 Feb; 33(2):235-45. PubMed ID: 17306694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.